Syncom Formulations (India) Limited (NSE:SYNCOMF)

Market Cap	15.66B
Revenue (ttm)	4.95B
Net Income (ttm)	575.57M
Shares Out	n/a
EPS (ttm)	0.65
PE Ratio	27.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	958,013
Average Volume	1,175,171
Open	16.90
Previous Close	16.72
Day's Range	16.50 - 16.95
52-Week Range	14.10 - 23.87
Beta	1.20
RSI	46.91
Earnings Date	Nov 14, 2025

About NSE:SYNCOMF

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 744
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SYNCOMF

Financial Performance

In 2024, NSE:SYNCOMF's revenue was 4.65 billion, an increase of 76.55% compared to the previous year's 2.63 billion. Earnings were 494.35 million, an increase of 95.28%.